Copyright ©ERS Journals Ltd 2001 Diagnostic significance of surfactant proteins A and D in sera from patients with radiation pneumonitis1 Third Dept of Internal Medicine and 2 Dept of Biochemistry, Sapporo Medical University School of Medicine CORRESPONDENCE: H. Takahashi, Third Dept of Internal Medicine, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo, 060-8543, Japan. Fax: 011 81116131543 Keywords: radiation pneumonitis, serum marker, surfactant proteins
Received: April 10, 2000
This
study was supported by a Grant-In-Aid for Scientific Research from
the Ministry of Education, Japan.
Radiation pneumonitis (RP) is the most common complication of
radiotherapy for thoracic tumours. The aim of this study was to evaluate the
significance of pulmonary surfactant proteins (SP)-A and
SP-D as new serum markers for RP.
Twenty-five patients with lung tumour, who had received radiotherapy,
were studied. At the completion of radiotherapy, the presence of RP was judged
by chest plain radiography and chest high resolution computed tomography (HRCT).
RP findings detected on chest plain radiography were seen in only three
of 12 patients in whom RP was detected by HRCT. Nevertheless, both SP-A
and SP-D concentrations in sera from the patients with RP were significantly
higher than those from the 13 patients without RP (p=0.0065, p=0.0011,
respectively). As with SP-A, ratios of SP-D at the completion,
compared to at the initiation (1 week post/pre ratio), were
also significantly higher in patients with RP than in patients without RP.
When a post/pre ratio>1.6 was considered positive, the SP-A
and SP-D assays showed an 83% and 85% specificity, respectively.
In conclusion, serum assays of surfactant proteins A and D may be of diagnostic
value for detection of radiation pneumonitis, even when the radiographic change
is faint.
| ||||||||||||||||||||||||